Sebela Ireland Ltd Drug Patent Portfolio
Sebela Ireland Ltd owns 2 orange book drugs protected by 6 US patents Given below is the list of Sebela Ireland Ltd's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8486456 | Itraconazole compositions with improved bioavailability | 03 Oct, 2028 | Active |
| US7598271 | Crystalline paroxetine methane sulfonate | 04 May, 2025 | Active |
| US5874447 | 4-Phenylpiperidine compounds for treating depression | 10 Jun, 2017 | Expired |
| US6509038 | Antifungal compositions with improved bioavailability | 12 May, 2017 | Expired |
| US7081255 | Antifungal compositions with improved bioavailability | 12 May, 2017 | Expired |
| US8591948 | Antifungal compositions with improved bioavailability | 12 May, 2017 | Expired |
Latest Legal Activities on Sebela Ireland Ltd's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Sebela Ireland Ltd.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 12 May, 2021 | US8591948 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Dec, 2020 | US8486456 |
|
Expire Patent
Critical
| 27 Aug, 2018 | US7081255 |
|
Maintenance Fee Reminder Mailed
Critical
| 05 Mar, 2018 | US7081255 |
| Post Issue Communication - Certificate of Correction | 30 Apr, 2014 | US8486456 |
| Petition Entered | 20 Mar, 2014 | US8486456 |
| Record a Petition Decision of Granted to Issue Patent in Name of the Assignee | 20 Mar, 2014 | US8486456 |
| Mail-Record a Petition Decision of Granted to Issue Patent in Name of the Assignee | 20 Mar, 2014 | US8486456 |
| Post Issue Communication - Certificate of Correction Denied | 12 Dec, 2013 | US8486456 |
|
Recordation of Patent Grant Mailed
Critical
| 26 Nov, 2013 | US8591948 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 26 Nov, 2013 | US8591948 |
|
Email Notification
Critical
| 07 Nov, 2013 | US8591948 |
|
Issue Notification Mailed
Critical
| 06 Nov, 2013 | US8591948 |
|
Application Is Considered Ready for Issue
Critical
| 30 Oct, 2013 | US8591948 |
| Dispatch to FDC | 30 Oct, 2013 | US8591948 |
Sebela Ireland Ltd's Family Patents
Sebela Ireland Ltd Drug List
Given below is the complete list of Sebela Ireland Ltd's drugs and the patents protecting them.
1. Onmel
Onmel is protected by 4 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8486456 | Itraconazole compositions with improved bioavailability |
03 Oct, 2028
(3 years from now)
| Active |
| US6509038 | Antifungal compositions with improved bioavailability |
12 May, 2017
(7 years ago)
| Expired |
| US7081255 | Antifungal compositions with improved bioavailability |
12 May, 2017
(7 years ago)
| Expired |
| US8591948 | Antifungal compositions with improved bioavailability |
12 May, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Onmel's drug page
2. Pexeva
Pexeva is protected by 2 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7598271 | Crystalline paroxetine methane sulfonate |
04 May, 2025
(2 months from now)
| Active |
| US5874447 | 4-Phenylpiperidine compounds for treating depression |
10 Jun, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pexeva's drug page